Chronic Kidney Disease-associated Pruritus

• EMA approval · 2026-02-12
  EMA Authorised: Kapruvia (difelikefalin) — Vifor Fresenius Medical Care Renal Pharma France

  The EMA authorised Kapruvia (difelikefalin) for chronic kidney disease–associated pruritus.

• FDA approval · 2025-03-25
  FDA Approved: KORSUVA — Supplemental Application (Vifor (International), Inc.)

  The FDA approved a supplemental application for Korsuva (difelikefalin) submitted by Vifor International, Inc., updating/expanding its label…

• FDA approval · 2021-08-23
  FDA Approved: KORSUVA — Original Application (Vifor (International), Inc.)

  FDA approved Korsuva (difelikefalin) for the treatment of moderate-to-severe pruritus in adults with chronic kidney disease on hemodialysis,…